Every at-home COVID-19 test that leaves Moose Pharmacy in Charlotte, NC, carries a sticker bearing a QR code. Beside the code, the text reads, “Test POSITIVE for COVID-19?" 

For pharmacists like Candis Morello who are treating patients using GLP-1 receptor agonists, it’s been a challenging few months navigating the shortage of this class of medications.

The value in expansion and protection of pharmacy technicians’ capabilities provided by the ninth amendment to the PREP Act has been incalculable in the face of the COVID-19 pandemic.

Antiretroviral therapy (ART) recommendations from the International Antiviral Society from December 2022 highlight novel long-acting injectables for PrEP and HIV treatment.

Clarissa Chan, PharmD

Few neurology practices in the United States have embedded pharmacists on their care teams, but a study published December 11, 2022, in the Journal of the American College of Clinical Pharmacy demonstrates how clinical pharmacists could positively affect patients in these settings.

Loren Bonner

Nonprescription products offer preparations to treat a wide range of ears, eyes, nose, and throat (EENT)–related disorders.

The Ninth Judicial District of the Court of Appeals of Ohio recently reversed the dismissal of a plaintiff’s lawsuit against a pharmacy that allegedly failed to provide the plaintiff with prescribed medication.

A patient recently reported that they had been inadvertently taking 2.5 mg of methotrexate—an antineoplastic and immunosuppressant agent—daily for nearly 3 months instead of 10 mg of prasugrel, an antiplatelet agent that had been prescribed.

Updates from FDA

According to CDC, 8.4% of adults took sleep medication either every day or most days to help them fall or stay asleep in 2020.

Mary Warner

S-adenosyl-l-methionine (SAMe) is a compound found naturally in the body, produced in the liver.

Mickie Cathers

For years, patients with asthma have been prescribed regimens that include several different inhalers, requiring them to remember the correct timing and situation for using each one.

Lauren Howell, PharmD

The latest CDC data find that deaths involving synthetic opioids like fentanyl increased by a staggering 80% over the past 2 years. These drugs were involved in more than two-thirds of the overdose deaths in the year ending March 2022.

Loren Bonner

Ninety-five percent of gabapentin prescriptions are written for off-label pain management, despite studies questioning gabapentin’s effectiveness for managing pain, and reports of its misuse with simultaneous opioid therapy.

Loren Bonner

Too often, clinicians question whether they are making the right decision about a patient’s anticoagulation therapy with planned, nonemergent surgical procedures.

Ariel L. Clark, PharmD

A new study published in JAMA investigated how various treatment interventions affected long-term outcomes in critically ill patients with COVID-19.

Olivia C. Welter, PharmD

Hydroxychloroquine and the risk for incident retinopathy.

On January 4, 2023, APhA hosted an open forum as part of the Pulse on Practice and Policy Open Forum Series to discuss the drug shortages that pharmacies are facing nationwide

Morgan Carson-Marino, PharmD, MS

Cardiovascular disease (CVD) is a significant global health issue.

Corey Diamond, PharmD

Over the course of the pandemic, researchers raced to find effective treatments for patients with COVID-19.

Lauren Howell, PharmD

Four new therapeutic agents are considered in this review, the first in a series of articles on new therapeutic agents marketed in 2022: tirzepatide (Mounjaro–Eli Lilly and Company), daridorexant hydrochloride (Quviviq–Idorsia), tenapanor hydrochloride (Ibsrela–Ardelyx), and vonoprazan fumarate in co-packaging with amoxicillin, and amoxicillin and clarithromycin (Voquezna–Phathom Pharmaceuticals).

Aimee Dawson, PharmD, Associate Professor of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences, Worcester; and Pharmacist, Holyoke Health Center, Holyoke, MA

Take the Crossword Challenge